Overall rank by patents
#47,542
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Humabiologics, Inc.
USPTO PatentsView assignee record — 5 granted patents across 6 technology areas, active 2024–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07K (PEPTIDES).
5
Total patents granted
6
CPC technology areas
11.4
Avg claims per patent
—
5-year filing velocity
Portfolio overview
Humabiologics, Inc. has been granted 5 US utility patents between 2024 and 2025, placing Humabiologics, Inc. at rank #47,542 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.4 claims per patent with primary concentration in C07K (PEPTIDES). As a US Corporation, Humabiologics, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 35.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2024 through 2025, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Humabiologics, Inc.'s 11.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Humabiologics, Inc. against peers pursuing similar technology classes.
How does Humabiologics compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Humabiologics ◀ 5
Humabiologics, Inc.
5 patents
What this shows Humabiologics holds 5 patents — placing it at rank #47,542 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2024–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 2 | 40.0% |
| 2025 | 3 | 60.0% |
Which technologies does Humabiologics, Inc. patent most?
Top 6 of 6 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Frequently Asked Questions
How many patents does Humabiologics, Inc. hold?
Humabiologics, Inc. holds 5 US granted patents filed between 2024 and 2025, spanning 6 technology areas.
What is Humabiologics, Inc.'s Innovation Score?
Humabiologics, Inc. has an Innovation Score of 35.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Humabiologics, Inc. focus on?
Humabiologics, Inc.'s top technology area is C07K (PEPTIDES) with 3 patents. The company has filed patents in 6 CPC subclasses total.
Is Humabiologics, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Humabiologics, Inc..
What does claim depth mean for Humabiologics, Inc.'s patents?
Humabiologics, Inc.'s patents average 11.4 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Humabiologics, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
C07K technology
Humabiologics, Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Humabiologics, Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
